Table 3 Clinical trial carried out with mesenchymal stem cells in canine atopic dermatitis
From: Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?
Specie (number) | Treatment | Results | Conclusion | Reference |
|---|---|---|---|---|
Dog (5) | Single IV autologous ASCs (1.3 million cells/kg) | No benefits of ASCs treatment were observed. | The dosage of ASCs was lower than employed in other studies. The results are inconclusive. | [54] |